BPH.AX
Get informed when a big investor buys or sells
+ FollowOvervalued by 15% based on the discounted cash flow analysis.
| Market cap | $2.71 Million |
|---|---|
| Enterprise Value | $491,698.00 |
| Dividend Yield | $- (-) |
| Earnings per Share | $-0.01 |
| Beta | 1.45 |
| Outstanding Shares | 1,284,687,293 |
| P/E Ratio | -0.28 |
|---|---|
| PEG | -0.01 |
| Price to Sales | - |
| Price to Book Ratio | - |
| Enterprise Value to Revenue | 0.59 |
| Enterprise Value to EBIT | -0.05 |
| Enterprise Value to Net Income | -1 |
| Total Debt to Enterprise | 0.13 |
| Debt to Equity | 0 |
No data
No data available for the latest quarter.
No data available for the latest quarter.
No data
Headquartered in Stirling, Australia, and established in 2001 (initially known as BioPharmica Limited), BPH Energy Limited maintains a diverse investment portfolio spanning biotechnology, oil and gas exploration and development, and the ...